Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Jack Khattar
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
central nervous system disorders
|
| gptkbp:founded |
2005
|
| gptkbp:founder |
Jack Khattar
|
| gptkbp:headquartersLocation |
gptkb:Rockville,_Maryland,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Supernus Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:numberOfEmployees |
over 500
|
| gptkbp:product |
gptkb:Trokendi_XR
APOKYN MYOBLOC Oxtellar XR Qelbree XADAGO |
| gptkbp:specializesIn |
neurology
psychiatry |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:tradedOn |
NASDAQ: SUPN
|
| gptkbp:website |
https://www.supernus.com/
|
| gptkbp:bfsParent |
gptkb:PhRMA
|
| gptkbp:bfsLayer |
6
|